Key Points - The stock of Renle will be delisted on July 4, 2025 [1] - Hualing Steel has been acquired by Xintai Life Insurance with a shareholding ratio of 5% [1] - Vanke A has applied for a loan of up to 6.249 billion yuan from Shenzhen Metro Group [1] - ST Yazhen has completed stock trading verification and will resume trading tomorrow [1] - Aerospace Chuangxin has regained procurement qualifications for military material engineering services [1] - Shangwei New Materials' controlling shareholder is planning a major event, and the stock will remain suspended [1] - Changling Hydraulic's actual controller is planning a change of control, and the stock will be suspended from tomorrow [1] - China Merchants Bank has been approved to establish China Merchants Financial Asset Investment Co., with a registered capital of 15 billion yuan [1] - Liugang Co. has experienced a potential irrational speculation risk with its stock [1] Operating Performance - Brothers Technology expects a net profit increase of 325% to 431.25% year-on-year for the first half of the year [1] - Huayin Power anticipates a net profit increase of 175 million to 215 million yuan year-on-year for the first half [1] - Xutian Salt Industry expects a net profit decrease of 76.34% to 80.29% year-on-year for the first half [1] - Juguang Technology expects a net loss of 42 million to 54 million yuan for the first half [1] - Beibu Gulf Port reported a cargo throughput of 31.1158 million tons in June, a year-on-year increase of 2.56% [1] - China Nuclear Power generated 115.104 billion kWh of electricity in the first half, a year-on-year increase of 15.92% [1] - Changyuan Power completed a power generation of 16.715 billion kWh in the first half, a year-on-year decrease of 8.3% [1] - Poly Developments signed contracts worth 29.011 billion yuan in June, a year-on-year decrease of 30.95% [1] Shareholding Changes - Jingye Da's actual controller plans to reduce holdings by no more than 3% [1] - Deyi Cultural Creation's actual controller Wu Tifang plans to reduce holdings by no more than 3% [1] - Caifu Trend's actual controller and chairman plan to reduce holdings by no more than 3% [1] - Annuo Qi's actual controller plans to reduce holdings by no more than 2% [1] - Suotong Development's actual controller and concerted actors plan to reduce holdings by no more than 2.21% [1] - Dingsheng Co.'s controlling shareholder plans to reduce holdings by no more than 1.71% [1] - Weitang Industrial's controlling shareholder plans to reduce holdings by no more than 1.95% [1] - Jinlong Automobile's Fujian Investment Group plans to reduce holdings by no more than 1% [1] - Wanye Enterprises' Guosheng Capital plans to reduce holdings by no more than 0.2% [1] - Zhonggang Luonai's Guoxin Shuangbai No.1 plans to reduce holdings by no more than 0.5% [1] - Funeng Technology's Shenzhen Anyan Investment plans to reduce holdings by no more than 1% [1] - Ankang Technology's Shenzhen High-tech Investment plans to reduce holdings by no more than 3% [1] - Donglai Technology plans to reduce no more than 1.2048 million repurchased shares [1] - Qujiang Cultural Tourism's controlling shareholder's 12 million shares are set to be auctioned [1] - Hesheng Silicon Industry's controlling shareholder plans to exchange no more than 1% of shares for ETF shares [1] Contract Awards - Boshi Co. signed an outsourcing service contract worth 109 million yuan with Guangxi Petrochemical [1] - Zhongyou Engineering's subsidiary signed a contract worth 294 million USD for the Atavi GMP pipeline project with Total Energy [1] - China Electric Power Construction's subsidiary signed a mining transportation project contract worth approximately 5.063 billion yuan [1] Other Developments - Xingxin New Materials plans to invest in a project with an annual output of 153,000 tons of polyolefin amine series products [4] - Haishun New Materials plans to acquire Sirewen Company to expand the application of electronic film materials in the semiconductor field [4] - Wankai New Materials is undergoing production reduction and maintenance, which is expected to significantly impact overall operating performance [4] - Donghu High-tech is participating in the establishment of the Donggao Frontier Phase II Fund to improve the development model of the park operation sector [4] - Jiete Biological plans to participate in the establishment of an industrial fund primarily investing in early and mid-stage biopharmaceutical projects [4] Asset Sales - Nord Shares plans to sell 70% equity of its wholly-owned subsidiary Jiangsu Lianxin for 70 million yuan [5]

Group 1: Company Announcements - China Merchants Bank has received approval to establish a wholly-owned subsidiary, China Merchants Financial Asset Investment Co., with a registered capital of 15 billion yuan, aimed at market-oriented debt-to-equity swaps and equity investment pilot projects [3] - Aerospace Chengtong has had its qualification for military material engineering service procurement restored after completing internal investigations and appeals [4] - Funiu Co.'s controlling shareholder has obtained a loan commitment of up to 162 million yuan from Bank of China Fujian Branch to increase its stake in the company [5] - Jiete Bio plans to establish a partnership fund with a total investment of 50.01 million yuan, focusing on early and mid-stage biopharmaceutical projects [6] - ST Yazhen's stock will resume trading on July 4 after completing a review due to a significant price deviation [7] - Xingxin New Materials intends to invest approximately 800 million yuan in a project to produce 153,000 tons of polyolefin amine series products in the China-Malaysia Qinzhou Industrial Park [8] - Changling Hydraulic's controlling shareholder is planning a change in control, leading to a temporary suspension of trading [9] - Xinda Real Estate's affiliate will provide up to 240 million yuan for asset renovation projects, with a 7-year term and a 5% annual interest rate [10] Group 2: Major Contracts - China Electric Power Construction has signed a mining transportation project contract worth approximately 5.063 billion yuan in Guinea, with a total project duration of about 72 months [12] - China Oil Engineering's subsidiary has signed a contract worth 294 million USD (approximately 2.122 billion yuan) for the Atawi GMP pipeline project in Iraq, which will positively impact future revenues and profits [13] - Boshi Co. has entered into an outsourcing service contract with China National Petroleum Corporation, valued at 109 million yuan over a 3-year period [14] Group 3: Performance Updates - Poly Developments reported a 30.95% year-on-year decrease in June contract amount to 29.011 billion yuan, with a total of 145.171 billion yuan for the first half of the year, down 16.25% [16] - Huayin Power expects a net profit increase of 175 to 215 million yuan for the first half of 2025, driven by increased power generation and reduced fuel costs [17]

| 证券代码：688026 | 证券简称：洁特生物 公告编号：2025-040 | | --- | --- | | 转债代码：118010 | 转债简称：洁特转债 | 广州洁特生物过滤股份有限公司 关于 2021 年限制性股票激励计划首次授予部分 第一个归属期的限制性股票第三次解除限售 暨上市流通的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次股票上市类型为股权激励股份；股票认购方式为网下，上市股数为 44,822股。 本次股票上市流通总数为44,822股。 本次股票上市流通日期为2025 年 7 月 11 日。 本次限制性股票激励计划首次授予部分第一个归属期的限制性股票第三 次解除限售安排如下： A、第一类激励对象 | 第一个归属期的限制性股 | 第三个解除限售期 | 25% | | --- | --- | --- | | 归属批次 票 | 限售批次 | 解除限售比例 | 一、本次上市流通的限售股类型 根据中国证监会、上海证券交易所、中国证券登记结算有限责任公司上海分公 司有关业务规则的规定， ...

一、关于拟对外投资设立产业基金的独立意见 本次对外投资设立产业基金事项符合公司的整体发展战略，有利于借助专 业投资机构的力量及资源优势通过股权投资进一步发掘具有产业协同效应的优 质项目，助力公司长远发展，审议程序符合《上海证券交易所科创板股票上市规 则》《上海证券交易所科创板上市公司自律监管指引第 1 号—规范运作》《公司 章程》的规定。本次对外投资使用公司自有资金或自筹资金，不会对公司财务和 经营状况产生不利影响，不存在损害公司、公司股东，特别是中小股东利益的情 形。同意公司本次对外投资设立产业基金的事项。 广州洁特生物过滤股份有限公司独立董事 关于第四届董事会第二十一次会议相关事项的独立意见 根据中国证监会《上市公司独立董事管理办法》《上海证券交易所科创板股 票上市规则》及《公司章程》等有关规定，我们作为广州洁特生物过滤股份有限 公司（以下简称"公司"）独立董事，本着对公司、全体股东负责的态度，基于 独立、客观、审慎的原则，现就公司关于第四届董事会第二十一次会议相关事项 发表如下独立意见： 广州洁特生物过滤股份有限公司 独立董事：洪炜、刘佳、陈锦棋 2025 年 7 月 3 日 ...

广州洁特生物过滤股份有限公司 信息披露暂缓与豁免业务管理制度 第一章 总则 第一条 为规范广州洁特生物过滤股份有限公司（以下简称"公司"）信 息披露暂缓、豁免行为，督促公司及相关信息披露义务人（以下统称"信息披 露义务人"）依法合规地履行信息披露义务，根据《中华人民共和国证券法》 《上市公司信息披露管理办法》《上市公司信息披露暂缓与豁免管理规定》《上 海证券交易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监 管指引第 1 号——规范运作》（以下简称"《规范运作》"）等法律法规、规 范性文件及《广州洁特生物过滤股份有限公司章程》（以下简称"《公司章 程》"）、《广州洁特生物过滤股份有限公司信息披露管理制度》（以下简称 "《信息披露管理制度》"）的有关规定，结合公司实际，制定本制度。 第二条 "信息披露义务人"是指公司、公司董事、总经理、财务负责 人、董事会秘书及其他高级管理人员；各部门、各控股子公司的主要负责人及 其相关工作人员；持有公司 5%以上股份的股东及其他公司关联人。 第三条 信息披露义务人按照相关法律法规、《规范运作》等规范性文件 及《公司章程》《信息披露管理制度》的规定办理信息披露暂缓、 ...

| 证券代码：688026 | 证券简称：洁特生物 公告编号：2025-042 | | --- | --- | | 转债代码：118010 | 转债简称：洁特转债 | 广州洁特生物过滤股份有限公司 关于拟对外投资设立产业基金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 拟投资基金名称：广州增城区南特生物医药投资合伙企业（有限合伙） （暂定名，最终以市场监督管理机关登记的名称为准；以下简称"产业基金""基 金"或"合伙企业"）。 ● 拟投资方向：主要投资于早、中期生物医药类项目，包括但不限于：精 准诊断试剂及 IVD、基因检测、细胞治疗、高端医疗器械国产化替代及材料研发、 智慧医疗与信息化、医疗大健康服务等领域，可与公司主营业务生命科学制品在 研发、应用等方面形成协同效应。 ● 拟投资金额：基金规模为人民币 5,001 万元，公司作为有限合伙人拟以 自有资金或自筹资金认缴出资人民币 2,500 万元，占总出资比例 49.99%。 ● 投资基金存续期限：合伙企业作为基金的存续期限为 7 年，自全体 ...

| 证券代码：688026 | 证券简称：洁特生物 | 公告编号：2025-041 | | --- | --- | --- | | 转债代码：118010 | 转债简称：洁特转债 | | 广州洁特生物过滤股份有限公司 第四届董事会第二十一次会议决议公告 公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 广州洁特生物过滤股份有限公司（以下简称"公司"）第四届董事会第二十一 次会议于 2025 年 7 月 3 日以现场及通讯相结合方式召开，会议通知已于 2025 年 7 月 2 日通过通讯方式送达全体董事，经全体董事一致同意豁免提前 5 日通知。 本次会议由董事长袁建华先生召集并主持，应参加董事 7 人，实际参加表决董 事 7 人。本次会议的召集、召开和表决程序均符合国家有关法律、法规及《公 司章程》等有关规定。经全体董事一致同意，形成决议如下： 特此公告。 具体内容详见同日刊载于上海证券交易所网站（www.sse.com.cn）的《关于 拟对外投资设立产业基金的公告》。 二、以 7 票同意，0 票反对，0 票弃权，审议通过了《关 ...

Core Viewpoint - Jiet Bio plans to establish an industrial fund to invest in early and mid-stage biopharmaceutical projects, with a total fund size of 50.01 million yuan [1] Investment Details - The fund will be initiated in partnership with Guangzhou Nanyue Aoyang Fund Management Co., Ltd. and Guangzhou Nanyue Fund Group Co., Ltd. [1] - Jiet Bio intends to contribute 25 million yuan, representing a 49.99% stake in the fund [1] - The partnership will have a duration of 7 years, with the first 4 years designated for investment and the last 3 years for exit [1] Transaction Nature - The investment does not constitute a related party transaction or a major asset restructuring [1]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 本季度转股情况：公司向不特定对象发行可转换公司债券证券"洁特转 债"自 2023 年 1 月 4 日起可转换为公司股份。自 2025 年 4 月 1 日至 2025 年 6 月 30 日期间，"洁特转债"共有人民币 0 元已转换为公司股票，转股数量为 0 股，占"洁特转债"转股前公司已发行股份总额的 0%。 | 证券代码：688026 | 证券简称：洁特生物 公告编号：2025-039 | | --- | --- | | 转债代码：118010 | 转债简称：洁特转债 | 广州洁特生物过滤股份有限公司 可转债转股结果暨股份变动公告 ● 累计转股情况：截至 2025 年 6 月 30 日，"洁特转债"累计有人民币 3,000 元已转换为公司股票，转股数量为 60 股，占"洁特转债"转股前公司已发行股 份总额的 0.00004%。 ● 未转股可转债情况：截至 2025 年 6 月 30 日，"洁特转债"尚未转股的 可转债金额为人民币 439,997,000 元 ...

Core Points - Jiet Bio (688026) closed at 15.86 yuan on June 27, 2025, up 5.17% from the previous week's 15.08 yuan [1] - The company's total market capitalization is 2.226 billion yuan, ranking 116th out of 126 in the medical device sector and 4825th out of 5151 in the A-share market [1] Company Announcements - Jiet Bio announced the interest payment for "Jiet Convertible Bonds" for the year 2025, with a face value of 100 yuan per bond and an interest amount of 1.00 yuan (including tax) [1] - The bond interest record date is June 27, 2025, with the ex-dividend date and payment date set for June 30, 2025 [1] - The company issued 4.4 million convertible bonds in June 2022, raising a total of 440 million yuan, with a six-year term and an increasing interest rate, reaching 1.00% in the third year [1] - The interest payment for this period covers from June 28, 2024, to June 27, 2025, with a net interest distribution of 0.80 yuan after a 20% personal income tax [1]